James Kyle Farquhar, PhD

Dr Farquhar is a board-certified clinical chemist through the National Registry of Certified Chemists. He earned a PhD in health services management from Century University.

Dr Farquhar has several decades of experience in laboratory medicine, including expertise in routine chemistry, toxicology, clinical laboratory regulations, and technical customer service.

Dr Farquhar also has served as a member of the American Association for Clinical Chemistry.

Chevonne Eversley, PhD, DABMG

Dr Eversley earned her PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill. She completed her postdoctoral training in molecular genetics at Mount Sinai School of Medicine in New York, and she is a fellow of the American College of Medical Genetics.

Dr Eversley is co-discipline director of the molecular genetics, genomic sequencing, and prenatal genomic screening laboratories at the Center for Molecular Biology and Pathology. She is responsible for oversight of molecular genetic interests at the facility.

Chevonne Eversley, PhD, DABMG

Dr Eversley earned her PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill. She completed her postdoctoral training in molecular genetics at Mount Sinai School of Medicine in New York, and she is a fellow of the American College of Medical Genetics.

Dr Eversley is co-discipline director of the molecular genetics, genomic sequencing, and prenatal genomic screening laboratories at the Center for Molecular Biology and Pathology. She is responsible for oversight of molecular genetic interests at the facility.

Zahra Shajani-Yi, PhD, DABCC

Dr Shajani-Yi earned her PhD from the University of Washington and completed her clinical chemistry fellowship at Dartmouth-Hitchcock Medical Center, in the Department of Pathology and Laboratory Medicine. She is a diplomate of the American Board of Clinical Chemistry (DABCC), a fellow of the American Association for Clinical Chemistry Academy (FAACC), and board-certified by the National Registry of Certified Chemists (NRCC). Prior to joining Labcorp, she was an assistant professor at Vanderbilt University School of Medicine and Medical Director of Esoteric Chemistry.

Zahra Shajani-Yi, PhD, DABCC

Dr Shajani-Yi earned her PhD from the University of Washington and completed her clinical chemistry fellowship at Dartmouth-Hitchcock Medical Center, in the Department of Pathology and Laboratory Medicine. She is a diplomate of the American Board of Clinical Chemistry (DABCC), a fellow of the American Association for Clinical Chemistry Academy (FAACC), and board-certified by the National Registry of Certified Chemists (NRCC). Prior to joining Labcorp, she was an assistant professor at Vanderbilt University School of Medicine and Medical Director of Esoteric Chemistry.

<span>Preparation, prevention: Screening for prediabetes before it gets worse</span>
October 31, 2022

Preparation, prevention: Screening for prediabetes before it gets worse

This Diabetes Awareness Month, we’re committed to helping you gain a better understanding of your health so you can take action. It is estimated that nearly 96 million U.S. adults have prediabetes, and more than 8 in 10 people do not realize they have it. Prediabetes, often reversible with healthy lifestyle changes, can cause health complications if left untreated or unmanaged. It can lead to Type 2 diabetes, heart disease, stroke, chronic kidney disease (CKD), colorectal cancer (CRC) and more.
<span>Enhancing the gaps in care program experience with patient-centered design</span>
October 27, 2022

Enhancing the gaps in care program experience with patient-centered design

Multiple agencies and organizations measure patient experience as a part of annual reporting and incentive opportunities (i.e., STARS, HCAHPS, NCQA, HEDIS®). When planning gaps in care programs, health plans and clinicians alike may use patient experience as a tool toward more effective interaction, communication and strategy in order to positively impact patients and ultimately, population health outcomes.
<span>Engaging patients to close care gaps</span>
October 27, 2022

Engaging patients to close care gaps

As payers and providers focus on improving patient quality and population health as well as reducing costs, patient engagement is a critical piece of the puzzle and one of the most important facets of Triple Aim. But it’s not easy. Millions of patients miss out on essential tests and preventive screenings for a wide variety of reasons.